Aigen Investment Management’s Concentrix CNXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-6,314
Closed -$291K – 651
2025
Q3
$291K Hold
6,314
– – 0.05% 544
2025
Q2
$334K Hold
6,314
– – 0.05% 494
2025
Q1
$351K Sell
6,314
-1,163
-16% -$55.7K 0.06% 449
2024
Q4
$324K Buy
+7,477
New +$333K 0.06% 454
2024
Q3
– Sell
-3,942
Closed -$249K – 773
2024
Q2
$249K Buy
+3,942
New +$237K 0.05% 550
2023
Q4
– Sell
-8,590
Closed -$688K – 833
2023
Q3
$688K Buy
8,590
+6,009
+233% +$471K 0.13% 260
2023
Q2
$208K Buy
+2,581
New +$241K 0.03% 605
2022
Q4
– Sell
-6,165
Closed -$688K – 567
2022
Q3
$688K Buy
+6,165
New +$789K 0.1% 256

Other funds holding CNXC

Aigen Investment Management's CNXC Position: Q4 2025 in Review

Aigen Investment Management sold out of Concentrix (CNXC) in Q4 2025, closing a stake of 6,314 shares — an estimated $291K sold.

Aigen Investment Management first reported a position in CNXC in Q3 2022 and held it in 8 quarters. The position peaked at $688K in Q3 2023. 337 funds tracked by Wall St. Rank hold CNXC as of Q4 2025.

  • Aigen Investment Management reported no remaining Concentrix position as of Q4 2025 after selling out during the quarter.
  • Aigen Investment Management sold 6,314 Concentrix shares in Q4 2025, an estimated $291K.
  • Aigen Investment Management first reported a position in Concentrix in Q3 2022 and held it in 8 quarters.
  • Aigen Investment Management's Concentrix position peaked at $688K in Q3 2023.
  • 337 funds tracked by Wall St. Rank held Concentrix as of Q4 2025.

Based on Aigen Investment Management's 13F filing for Q4 2025, filed 13 Feb 2026.